Hangcheng Fu
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Galectins and Cancer Biology
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Surgery 12
- Bladder and Urothelial Cancer Treatments 10
-
- Renal cell carcinoma treatment 7
- Ferroptosis and cancer prognosis 3
- Co-authors
- Jiejie Xu (20 shared papers)Yu Zhu (13 shared papers)Huyang Xie (10 shared papers)Qiang Fu (10 shared papers)Junyu Zhang (9 shared papers)Bo Dai (9 shared papers)Le Xu (7 shared papers)Zheng Liu (3 shared papers)
- Journals
- Oncotarget (8 papers)Urologic Oncology Seminars and Original Investigations (3 papers)OncoImmunology (2 papers)World Journal of Urology (2 papers)Tumor Biology (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Hangcheng Fu
33 papers receiving 722 citations
Peers
Comparison fields: 5 of 64
- Immunology 249
- Cancer Research 136
- Oncology 217
- Pulmonary and Respiratory Medicine 153
- Surgery 141
Countries citing papers authored by Hangcheng Fu
This map shows the geographic impact of Hangcheng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangcheng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangcheng Fu more than expected).
Fields of papers citing papers by Hangcheng Fu
This network shows the impact of papers produced by Hangcheng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangcheng Fu. The network helps show where Hangcheng Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hangcheng Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 172 | |
| 2 | 2018 | 128 | |
| 3 | 2018 | 65 | |
| 4 | 2016 | 37 | |
| 5 | 2016 | 35 | |
| 6 | 2015 | 32 | |
| 7 | 2015 | 28 | |
| 8 | 2016 | 25 | |
| 9 | 2017 | 22 | |
| 10 | 2019 | 20 | |
| 11 | 2017 | 17 | |
| 12 | 2016 | 17 | |
| 13 | 2018 | 15 | |
| 14 | 2016 | 15 | |
| 15 | 2016 | 13 | |
| 16 | 2016 | 12 | |
| 17 | 2016 | 12 | |
| 18 | 2017 | 12 | |
| 19 | 2023 | 10 | |
| 20 | 2017 | 7 |
About Hangcheng Fu
Hangcheng Fu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Immunology, Oncology and Molecular Biology, having authored 33 papers that have together received 731 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (7 papers), Renal and related cancers (4 papers), Ferroptosis and cancer prognosis (3 papers), Galectins and Cancer Biology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Mast cells and histamine (3 papers) and Heavy Metal Exposure and Toxicity (3 papers). The work is most often cited by research in Immunology (249 citations), Cancer Research (136 citations), Oncology (217 citations), Pulmonary and Respiratory Medicine (153 citations) and Surgery (141 citations). Hangcheng Fu has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Jiejie Xu, Yu Zhu, Huyang Xie, Qiang Fu, Junyu Zhang, Bo Dai, Le Xu, Zheng Liu, Zewei Wang and Weijuan Zhang. Their work appears in journals such as Oncotarget, Urologic Oncology Seminars and Original Investigations, OncoImmunology, World Journal of Urology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.